• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The challenge of nonvariceal upper GI bleeding management in patients with acute coronary syndrome receiving dual-antiplatelet therapy.

作者信息

Saltzman John R

机构信息

Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Gastrointest Endosc. 2020 Jul;92(1):75-77. doi: 10.1016/j.gie.2020.03.012.

DOI:10.1016/j.gie.2020.03.012
PMID:32586567
Abstract
摘要

相似文献

1
The challenge of nonvariceal upper GI bleeding management in patients with acute coronary syndrome receiving dual-antiplatelet therapy.接受双联抗血小板治疗的急性冠状动脉综合征患者非静脉曲张性上消化道出血的管理挑战。
Gastrointest Endosc. 2020 Jul;92(1):75-77. doi: 10.1016/j.gie.2020.03.012.
2
[Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].经皮冠状动脉介入治疗术后患者双联抗血小板治疗联合质子泵抑制剂安全性和有效性的Meta分析
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Feb 24;47(2):129-140. doi: 10.3760/cma.j.issn.0253-3758.2019.02.010.
3
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.基于普拉格雷的急性冠状动脉综合征患者经皮冠状动脉介入治疗后双联抗血小板治疗降级（HOST-REDUCE-POLYTECH-ACS）：一项开放标签、多中心、非劣效性随机试验。
Lancet. 2020 Oct 10;396(10257):1079-1089. doi: 10.1016/S0140-6736(20)31791-8. Epub 2020 Aug 31.
4
Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.当代急性冠状动脉综合征患者中，心肌梗死与出血严重程度对死亡率的预后影响差异
Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12.
5
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.急性冠状动脉综合征患者经皮冠状动脉介入治疗后 6 个月与 12 个月或更长时间双联抗血小板治疗（SMART-DATE）：一项随机、开放标签、非劣效性试验。
Lancet. 2018 Mar 31;391(10127):1274-1284. doi: 10.1016/S0140-6736(18)30493-8. Epub 2018 Mar 12.
6
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).急性冠状动脉综合征行经皮冠状动脉介入治疗患者中当代口服抗血小板治疗指南的实施：来自希腊抗血小板登记研究（GRAPE）的报告。
Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15.
7
Efficacy and Safety of Different Antiplatelet Strategies in Survivors of Myocardial Infarction With Acute Coronary Syndrome.急性冠状动脉综合征心肌梗死后不同抗血小板策略的疗效和安全性。
Clin Ther. 2019 Oct;41(10):2090-2101.e1. doi: 10.1016/j.clinthera.2019.08.007. Epub 2019 Sep 7.
8
Dual antiplatelet therapy in acute coronary syndrome after stent implantation: How short is short and how long is long?支架植入术后急性冠状动脉综合征的双联抗血小板治疗：多短算短，多长算长？
Hellenic J Cardiol. 2018 Nov-Dec;59(6):376-377. doi: 10.1016/j.hjc.2018.11.010. Epub 2019 Jan 23.
9
MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.对接受直接血管成形术并同时使用普拉格雷或氯吡格雷进行上游抗血小板治疗的ST段抬高型心肌梗死患者的多国非干预性研究——欧洲MULTIPRAC注册研究
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):220-9. doi: 10.1177/2048872614547449. Epub 2014 Sep 2.
10
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的抗血小板治疗降级指导（TROPICAL-ACS）：一项随机、开放标签、多中心试验。
Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.

引用本文的文献

1
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial.急性心肌梗死后幽门螺杆菌筛查：群组随机交叉HELP-MI瑞典心脏注册研究试验
JAMA. 2025 Sep 1. doi: 10.1001/jama.2025.15047.
2
Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review.有广泛冠状动脉疾病史的胃肠道出血患者的双重抗血小板治疗：一项系统评价
Ann Med Surg (Lond). 2025 Apr 25;87(6):3715-3735. doi: 10.1097/MS9.0000000000002833. eCollection 2025 Jun.
3
Risk Factors for Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction: Multicenter Retrospective Cohort Study.
急性心肌梗死患者发生胃肠道出血的危险因素：多中心回顾性队列研究
J Med Internet Res. 2025 Jan 30;27:e67346. doi: 10.2196/67346.